Patent · US Active

Nucleic acids encoding anti-VEGF-A antibodies and uses thereof

US11634483B2 · kind B2 · utility

0Cited by
0References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 19, 2021
Grant dateApr 25, 2023
Priority date
Expiry dateSep 17, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to antibodies having activity against a vascular endothelial growth factor (VEGF), and methods of making and using such antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.